论文部分内容阅读
摘要目的乳腺MRI评价芳香酶化抑制剂(AI)对既往有乳腺癌史的绝经后妇女乳腺实质强化(BPE)及乳腺纤维腺体含量(FGT)的影响。材料与方法本研究为符合HIPAA的回顾性研究,获得机构审查委员会批准,并豁免了对知情同意的要求。
Abstract Objective To evaluate the effect of aromatase inhibitor (AI) on breast parenchymal enhancement (BPE) and fibroid glandular fiber (FGT) in postmenopausal women with a history of previous breast cancer. Materials and Methods The study was approved by the Institutional Review Board to comply with the HIPAA retrospective study and waived the requirement for informed consent.